ACAD ACADIA Pharmaceuticals Inc. Buxgalteriya kapitallashuvi

Ommaviy kompaniya ACADIA Pharmaceuticals Inc. (ACAD) logotipi

ACADIA Pharmaceuticals yetakchi Markaziy Nerv Tizimi (CNS) ekspertlarini birlashtirib, tadqiqot va ishlanmalar (R&D) grantlari hamda imkoniyatlari orqali dori vositalarini ishlab chiqish uchun axloqiy muhit yaratmoqda. GURU.Markets platformasidagi aksiya narxi tarixi 1.30 miqdorida qayd etilgan. Kompaniya asab tizimi buzilishlariga qarshi terapiyalarga e'tibor qaratib, Parkinson kasalligi psixozi uchun davolash vositasini monetizatsiya qilmoqda va Rett sindromi kabi kam uchraydigan genetik patologiyalar segmentiga kengaymoqda.

ACAD ACADIA Pharmaceuticals Inc. Balans kapitallashuvi (04.07.2022 - 27.10.2026)

ACADIA Pharmaceuticals Inc. (ACAD) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi ACADIA Corp|ACAD - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi ACADIA Pharma|ACAD - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga xususiy kapital ACADIA Pharmaceuticals|ACAD - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti acadia-pharm.com|ACAD - Kompaniyaning yakuniy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati ACADIA Pharmaceuticals|ACAD - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati ACADIA Pharma|ACAD - Kompaniya qarzlari|Balans qiymatiga qarzlar ACADIA Pharma
Kompaniyaning jamlanma tahlili:ACAD - ACADIA Corp
ACADIA Pharma yetakchi tovari

Markaziy nerv tizimi (CNS) sektoridagi shiddatli patent poygasi fonida, ushbu ko'rsatkich qarz majburiyatlaridan tozalangan ACADIA Pharmaceuticals (ACAD) kompaniyasining real aktiv qiymatini baholash imkonini beradi. Metrikaning hisob-kitobi sof kapital qiymatining kunlik aniqlanishiga asoslangan bo'lib, bu bozor buzilishlarini va inflyatsion shovqinlarni bartaraf etadi. Balans hisoboti orqali korxona kapitalizatsiyasi darajasini tahlil qilish investorlarga biznesning adolatli qiymatini aniqlashga va haddan tashqari qimmat baholangan qimmatli qog'ozlarni sotib olishdan qochishga yordam beradi.

ACADIA Pharmaceuticals raqobatchilari tahlili

BIIB - Balans kapitallashuvi|Balans kapitallashuvi Neurocrine Biosciences|RGC (regencellbioscience.com) - Buxgalteriya kapitallashuvi|Kompaniyaning balans qiymati Axsome Therapeutics, Inc. (AXSM)|Buxgalteriya kapitallashuvi Xenon Pharmaceuticals Inc.|Viking Pharma - Balans kapitallashuvi|Kompaniyaning xususiy kapitali Supernus Corp SUPN|Kompaniyaning sof aktivlari CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Balans kapitallashuvi|Kompaniyaning balans qiymati Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati AMLX|Trevi Corp (TRVI) - Kompaniyaning xususiy kapitali|PRAX (Praxis Precision Medicines) - Balans kapitallashuvi|Balans kapitallashuvi anavex.com|Balans kapitallashuvi CBLL (CeriBell)|Kompaniyaning sof aktivlari Prothena Corporation (PRTA)|Balans kapitallashuvi ALEC (Alector)|Balans kapitallashuvi Annexon Biosciences Inc. ANNX|Omeros Corp. (OMER) - Balans kapitallashuvi|NGNE - Buxgalteriya kapitallashuvi|AC Immune SA - Balans kapitallashuvi|Voyager Therapeutics Inc (VYGR) - Biznesning balans bahosi|NMRA (Neumora Therapeutics Inc) - Balans kapitallashuvi|Balans kapitallashuvi Scilex Holding Company, Inc. (SCLX)|Tevogen Bio Holdings (TVGN) - Kompaniyaning sof aktivlari|Kompaniyaning buxgalteriya qiymati ACOG (alphacognition.com)|Cognition Therapeutics (CGTX) - Kompaniyaning balans qiymati|Sof aktivlar qiymati Inhibikase Therapeutics Inc IKT|Balans kapitallashuvi Cassava (SAVA)|ASRT - Kompaniyaning buxgalteriya qiymati|COYA: Balans kapitallashuvi|VTGN (Vistagen) - Balans kapitallashuvi|OVID - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati ABOS|Kompaniyaning balans qiymati CRVO (CervoMed Inc)|Kompaniyaning sof aktivlari alteritytherapeutics.com (ATHE)|Balans kapitallashuvi CLNN (Clene)|Balans kapitallashuvi PepGen Inc PEPG|JUNS: Balans kapitallashuvi|RLMD - Kompaniyaning sof aktivlari|Balans kapitallashuvi ANVS|Kompaniyaning xususiy kapitali Grace Therapeutics|AIFF (Firefly Neuroscience, Inc) - Kompaniyaning sof aktivlari|Balans kapitallashuvi ANEW Medical, Inc. (KLTO)|Kompaniyaning sof aktivlari NeuroSense Therapeutics|Jami sof aktivlar Reviva Pharmaceuticals Holdings Inc. (RVPH)|Balans kapitallashuvi MTVA|Biznesning balans bahosi NeurAxis Inc NRXS|HSDT: Balans kapitallashuvi|PASG - Kompaniyaning sof aktivlari|NEUP: Balans kapitallashuvi|NERV (Minerva Neurosciences Inc) - Balans kapitallashuvi|Kompaniyaning balans qiymati Athira|Kompaniyaning balans qiymati ADXN|ALZN (Alzamend Neuro, Inc.) - Kompaniyaning balans qiymati|Biznesning balans bahosi cyclerion.com (CYCN)|Balans kapitallashuvi PTIX (Protagenic Therapeutics, Inc.)|Balans kapitallashuvi Pasithea Therapeutics Corp KTTA|CRGT: Balans kapitallashuvi|ATXI - Kompaniyaning sof aktivlari|BCLI: Balans kapitallashuvi|caratherapeutics.com (CARA) - Balans kapitallashuvi|Balans kapitallashuvi Chromocell Therapeutics Corp. (CHRO)|Buxgalteriya kapitallashuvi ELYM|Kompaniyaning balans qiymati Intra-Cellular Therapies ITCI|Buxgalteriya kapitallashuvi Longboard (LBPH)|MRNS: Balans kapitallashuvi|NKGN - Kompaniyaning xususiy kapitali|NeuroBo Pharmaceuticals, Inc. - Kompaniyaning sof aktivlari|SAGE: Balans kapitallashuvi|Kompaniyaning balans qiymati Neurotrope SNPX|TRVN (Trevena Inc) - Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati VIGL (Vigil Neuroscience Inc.)|Kompaniyaning xususiy kapitali Anew Medical Inc.|Balans kapitallashuvi CERE